The negative psychosocial implications stemming from diabetes are well established. For example, people with diabetes are almost 2 times more likely to have clinical depression than those who do not have the disease. 1,2 However, an emerging facet of these psychosocial burdens encountered by those with diabetes is gaining exposure in scientific literature and in clinical practice. These burdens, known as "diabetes distress," include frustrations with glycemic control, worries about complications, stresses the disease imposes on interpersonal relationships, and/or negative encounters with their health care team.
Background
The negative psychosocial implications stemming from diabetes are well established. For example, people with diabetes are almost 2 times more likely to have clinical depression than those who do not have the disease. 1, 2 However, an emerging facet of these psychosocial burdens encountered by those with diabetes is gaining exposure in scientific literature and in clinical practice. These burdens, known as "diabetes distress," include frustrations with glycemic control, worries about complications, stresses the disease imposes on interpersonal relationships, and/or negative encounters with their health care team. 3 Diabetes distress is thought to affect 40% of those with diabetes, but may be missed if the only type of physiological screening performed is for clinical depression. 3 Interestingly, 70% of those with diabetes distress do not have clinical depression, but this does not mean they are without the negative ramifications that accompany distress. 3 Diabetes distress has been associated with worse glycemic control, poorer medication adherence, decreased quality of life, and an increase in depression. [4] [5] [6] [7] Therefore, it is important that diabetes educators seek to understand underlying factors that contribute to the emotional distress.
The presence of diabetes distress is not necessarily permanent. Many interventions, primarily educational, can decrease the extent of diabetes distress. [8] [9] [10] [11] [12] Some interventions that have been successful at decreasing diabetes distress include models that incorporate cognitive behavior therapy and web-based, self-guided education. [8] [9] [10] [11] [12] Expectedly, the structured diabetes self-management education (DSME) led by registered nurses and dieticians in both the individual and group settings have also been effective at decreasing diabetes distress markers.
11 DSME serves to improve the wellbeing of those with diabetes by increasing diabetes-related knowledge and advancing practical skills to empower patients to manage diabetes in their day-to-day life. 13 The Diabetes Standards of Medical Care 2018 released by the American Diabetes Association emphasize the value of DSME by recommending that patients receive DSME not only at diagnosis but also when new complicating factors arise, when a transition of care occurs, and if deemed necessary by the provider-such as after implementing a new medication to a patient's regimen. 1 Though DSME has shown to have favorable effects on clinical and economic outcomes, it is still widely underutilized. 13, 14 Therefore, structured education has increasingly been incorporated into nontraditional settings, such as community pharmacies, in order to increase access of education to communities. 15 However, the current impact pharmacists may have in reducing diabetes distress, particularly in the setting of a community pharmacy-based DSME model, is unknown.
The purpose of this study is to evaluate the impact that a community pharmacy DSME program has on diabetes distress. This study hypothesizes that a community pharmacy DSME model decreases diabetes distress markers in participants.
Methods

Design
This retrospective observational study evaluated patient charts of those who completed Blount Discount Pharmacy's DSME course. The Problem Areas in Diabetes (PAID) scores, the study's primary outcome, were collected from patient-reported surveys that served as a quality improvement metric for the program. The PAID scale surveys were administered by paper to program participants at the start of the initial diabetes education session and end of the final session. Data were manually collected from patient charts using Microsoft Excel and analyzed using inferential and descriptive statistics. The Statistical Package for the Social Science (SPSS) Version 11.0 (SPSS Inc, Chicago, IL) was used to analyze the primary endpoint's change from baseline through the use of the paired t test.
This study was approved by the University of Tennessee Health Science Center Institutional Review Board (Approval 16-04426-XP).
Evaluation Instrument
The PAID scale is a validated, reliable tool used in scientific literature to evaluate diabetes distress. 16, 17 The PAID questionnaire consists of 20 diabetes-specific, negative emotion statements, shown in Figure 1 . Responses to each statement are ranked on a 5-point Likert-type scale between 0 (not a problem) and 4 (serious problem), with greater scores indicating a higher degree of distress. Subscores are totaled and multiplied by 1.25 for a final score, which may range from 0 to 100. Total scores ⩾40 indicate a high degree of diabetes distress. 17 used, there is not yet a gold standard. Compared with the Diabetes Distress Scale, the PAID scale has a greater emphasis on nutrition-and diabetes-related complications and was thus chosen as the evaluation instrument.
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Setting and Participants
Blount Discount Pharmacy is a high-volume, independently owned retail community pharmacy located in East Tennessee. Several patient care services are offered at this site, including medication therapy management, medication prepackaging, medication synchronization, immunizations, and a DSME program. The pharmacy's DSME program received accreditation by the American Association of Diabetes Educators in July 2015.
Inclusion criteria for chart evaluation included patients who were at least 18 years old and completed the pharmacy's DSME curriculum between August 1, 2015, and February 10, 2016. Figure 2 illustrates the structure of Blount Discount Pharmacy's DSME course. A patient is enrolled in the DSME program after his or her primary care provider sends a referral for structured diabetes education to the pharmacy. Each enrolled patient receives 1 hour of individual, one-on-one diabetes education with a pharmacist. The session includes an individual assessment of medical and medication histories as well as a review of diabetes history and current glycemic status. Motivational interviewing is used to provide tailored education and shared decision-making.
Intervention
Following individual education, a patient may participate in 9 hours of group education. This consists of 3 classes covering self-management content based on the American Association of Diabetes Educators Diabetes Education Curriculum: A Guide to Successful Self-Management (First Edition; Table 1 ). The classes are held approximately every other week. Target group size ranges from 2 to 8 patients and/or a support guest. Of note, 3 hours of the curriculum is dedicated to nutrition education. This content is taught by a partnering registered dietician/certified diabetes educator (CDE). The remaining 6 hours of the curriculum are led by a Blount Discount non-CDE pharmacist.
The classes are designed to be conversational in nature, allowing for patients to share their experiences with diabetesincluding barriers, fears, and successes, among others-and ask questions. A patient is encouraged to create a SMART (specific, measurable, achievable, realistic, and timely) goal after each education session. A pharmacist follows up with the patient, either in person (preferred) or via telephone, at various intervals once the course is completed. The pharmacist informs the patient's referring physician of the DSME encounter and patient-specific barriers and successes. The pharmacist may recommend medication or testing supplies adjustments, though regimen changes are executed solely by the patient's medical provider.
Outcomes
Baseline characteristics such as patient age and gender were collected to gain insight on the demographics of the population. It was noted if the patient was previously an established customer of Blount Discount Pharmacy in order to evaluate a patient-pharmacist relationship existed prior to the intervention ( Table 2) .
The magnitude of diabetes distress may vary depending on the duration and severity of diabetes as well as the intensity their treatment regimen. Therefore, information of diabetes type, length of diagnosis, and A1C prior to DSME was collected ( Table 2 ). Intensity of treatment for this population was noted by patients' medication history-specifically by the number of total medications a patient reported taking and if they were on oral and/or injectable diabetes medications. Patients with diabetes may also be at higher risk for comorbidities such as cardiovascular disease or depression. Medications used for these comorbidities, or even lack thereof, may impose additional distress on the patient, and thus, it was noted if a patient reported taking medication to treat hypertension, cholesterol (as noted by a statin medication), and/or depression.
The primary endpoint of this study evaluated the change in PAID scale score after completion of Blount Discount Pharmacy's DSME program, where total scores ⩾40 indicate a high degree of diabetes distress. 18 Per the program's quality improvement protocol, enrolled patients complete the questionnaire at the start of the individual consultation and after the last group education class in the series the patient attends.
Results
Patient Population
Seventeen patients met the specified inclusion criteria. The demographic information (Table 2) shows that the majority of the patients were female. Additionally, most patients were white (non-Hispanic), while one female was African American. The mean age of the sample was 63 years, and less than half (41%) of the sample regularly used the pharmacy for their prescriptions.
Diabetes History
While all patients in the sample had type 2 diabetes mellitus, the length of time since an individual's diagnosis varied (Table 2 ). Roughly half of the population (53%) were diagnosed with diabetes within the previous 12 months. The remaining half (47%) had a long-standing history of diabetes prior to starting DSME. While the criterion for this category was set at ⩾12 months since diagnosis, the average length of diabetes in this subgroup was roughly 20 years (Table 2) .
Medications
Since pharmacists are uniquely trained in medication management, knowing the medication history of the population may help shed light on not only a potential contributor to distress but also an area where pharmacists may have significant impact. 19 The mean number of medications reported by the patient was 8.7. Of note, over one third of the population was on insulin therapy. Patients taking insulin must be more vigilant checking blood glucose levels, require at least once daily injections, may have to interpret sliding scales, and are at increased risk of hypoglycemia. For these reasons, those on insulin may experience a higher degree of diabetes distress. 20 Also, diabetes distress and depression are thought to share a bidirectional relationship. 4 Thus, it is important to note that 47% of the population was on an antidepressant medication.
Change in PAID Scale Scores
The results for the primary endpoint are expressed in Table 3 . The mean diabetes distress score reported by patients before diabetes education crossed the "highly distressed" (total score ⩾40) threshold. 18 After completion of the pharmacy's DSME course, scores significantly decreased more than 23% (P = .029), bringing the mean distress score below the threshold for clinical distress. A paired t test analysis of a subgroup of the population shows that those on insulin therapy had a higher baseline distress score than those who were not on insulin. However, the total reduction in PAID scale scores was roughly the same (23% vs 27%; Table 3) .
A secondary analysis showed that patients with a diagnosis of diabetes for at least 12 months (average 20 years) experienced a greater magnitude of diabetes distress reduction compared with those with a more recent diagnosis of diabetes (27% vs 19% reduction, respectively; Figure 3 ). Of note, insulin therapy was utilized by 50% of patients with diabetes diagnosis of ⩾12 months and by 37% of patients with diabetes diagnosis <12 months prior to the start of DSME.
Discussion
This is the first study to evaluate the impact that the community pharmacist may have in the reduction of diabetes distress. While the community pharmacy DSME model is still relatively unfamiliar, it follows the shifting landscape of community pharmacy care. 21 The advancement of clinical services beyond medication dispensing, such as pharmacist-administered vaccinations or medication therapy management, has proven to have clinical and economic benefits in health care. [22] [23] [24] [25] Small studies that incorporate the community pharmacist into diabetes care have been successful in decreasing A1C, but the particular impact that a pharmacist has in reducing diabetes distress has not been reported-this may be a niche for community pharmacists as they not only are professionally trained in diabetes but also are medication experts. 15, 25 Helping a patient with diabetes overcome medication-related barriers such as costs, injection technique, pill organization, blood glucose selfmonitoring technique, and adverse effect minimization may decrease overwhelming feelings contributing to distress or "burnout." It would be valuable for future studies to evaluate change in individual subsets of the PAID questionnaire in order to observe particular areas that pharmacists may have the most influence in their education. Perhaps a pharmacist-led DSME reduces distress parameters such as "feeling discouraged with your treatment plan" and "worrying about low blood sugar reactions" greater than other problem areas due to a pharmacists' extensive training on medication therapy and adverse effects. Likewise, it may also reveal additional training opportunities for a pharmacist involved in DSME.
As expected, the results of this study found that patients who were on insulin therapy had a higher degree of diabetes distress at baseline, but the reduction of distress was similar to those who were not on insulin. This study unexpectedly found a greater reduction in diabetes distress scores after completion of DSME in those who had a long-standing history of diabetes. Though not objectively tracked, most patients in the study who had diabetes within the past year were actually diagnosed at the time the referral for education was sent to the pharmacy-implying that the pharmacy DSME program was the patient's first and primary means of diabetes education. Several patients in this category actually had higher PAID scale scores after completion of the course indicating that they had more distress after the formal education. Contributing factors are infinite, but the authors hypothesize these patients became more aware of the responsibilities of diabetes care and the consequences of poor management. Realization of these factors may have contributed to higher PAID scores. They have also had less time to experience social and relational stressors that their new disease state may impose on their normal lives. Additionally, they tended to be on less injections and medications, most notably insulin, than their long-standing diabetes counterparts, who have had extensive time to experience the difficulties and frustrations of living with diabetes. This supports the American Diabetes Association's push for the value in recurring education at critical points and not merely at diagnosis.
Limitations
Overall, the study size was small with 17 patient cases reviewed and had a limited demographic makeup of participants. Future studies should be prospective and determine population size a priori to reach adequate power to detect statistical significance. Additionally, all patients in the sample had type 2 diabetes. A cross-sectional analysis investigating distress, depression, and glycemic control reported that diabetes distress scores were not significantly different between the 2 subtypes of diabetes, but the investigators of this study feel that the diabetes distress reduction observed in this should not be assumed to be reflective of type 1 patients. 26 The purpose of this study is to evaluate the potential that a pharmacist-led DSME program may have in reducing diabetes distress, so it should be considered that a registered dietician (who is a CDE) led the nutrition portion of the group education. Thus, the extent of distress reduction attributed to interventions from pharmacists versus dietician cannot be compartmentalized. The investigators feel that by embracing interdisciplinary health care professionals such as a dietician in the program, patients receive a wider extent of specialized expert education.
The study was limited in its prospective conclusions due to little time allowed for follow-up after completion of the DSME course. Patients were given the post-DSME PAID scale immediately following the last group education class. An improved marker of the reduction in diabetes distress may be evident if patients were administered the post-DSME PAID scale after a period of time that would allow the patient to apply the knowledge and skills that were learned at the final education session.
Implications for Diabetes Educators
DSME is a cornerstone in improving glycemic and psychosocial outcomes for those with diabetes. With increased attention to the value of this service, a greater demand will be placed on diabetes educators. The results of this study give further credit to the community pharmacy DSME model and propose that pharmacists may be excellent additions to diabetes education teams to meet an increase in demand for diabetes educators. Pharmacists, even those who are not CDEs, are well positioned in education, training, and location to meet the growing need of Diagnosed ≥ 12 mo (n=8)
PAID Scale Score
Mean Pre-DSME Mean Post-DSME Figure 3 . Change in PAID scale score based on length of diabetes. Those who were diagnosed with diabetes within the previous 12 months of education (left) experienced a 19% reduction in mean pre-and post-DSME PAID scale scores, while those who were diagnosed with diabetes at least 12 months before the start of education experienced a 27% reduction in mean pre-and post-DSME PAID scale score. Bolded line represents threshold for "highly distressed" categorization.
Abbreviations: PAID, Problem Areas in Diabetes; DSME, Diabetes Self-Management Education.
quality diabetes education. Importantly, pharmacy-based diabetes educators should look for referral sources outside of their own patient population as participants within the present study were referred to the pharmacy by medical offices.
Conclusion
The results of this retrospective study found that an overall statistically significant reduction in PAID scale scores in those who completed the community pharmacy-based DSME program. This suggests that community pharmacist-managed diabetes education programs may have a positive impact in the reduction of the psychosocial burden that patients with diabetes face. Future prospective studies with a larger sample size are recommended to support these observations.
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